Using hypnosis to improve comfort during non-invasive ventilation for COPD and obese patients in intensive care
HYVIR : Interest of Hypnosis During the Implementation of Non-invasive Ventilation in a Patient With COPD and/or Obesity With a BMI Greater Than 30, Conscious With Acute Respiratory Distress in the Adult Intensive Care Unit
This study is testing if using hypnosis can help make patients with COPD and obesity feel more comfortable during non-invasive ventilation in the intensive care unit.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Rennes University Hospital Academic / other |
| Locations | 1 site (Rennes, Brittany Region) |
| Trial ID | NCT04220463 on ClinicalTrials.gov |
What this trial studies
This study investigates the use of hypnosis as a complementary approach to enhance comfort and tolerance during non-invasive ventilation (NIV) in patients with chronic obstructive pulmonary disease (COPD) and/or obesity in an intensive care setting. The trial focuses on patients experiencing acute respiratory distress, where traditional pharmacological treatments may pose risks. By integrating hypnosis with NIV, the study aims to reduce discomfort and improve the overall effectiveness of the ventilation therapy. Participants will be closely monitored to assess the impact of hypnosis on their ability to tolerate NIV.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and over with acute respiratory failure due to COPD and/or obesity (BMI greater than 30) who are conscious and able to provide informed consent.
Not a fit: Patients in extreme respiratory distress requiring immediate intervention or those with confusional states or severe psychiatric illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve patient comfort and outcomes during critical respiratory interventions.
How similar studies have performed: While hypnosis has been explored in various medical contexts, this specific application in conjunction with NIV for COPD and obesity is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Pre-inclusion criteria * Man or woman, aged 18 or over, admitted to medical intensive care * Glasgow score = 15 * Patient with acute respiratory failure decompensating COPD and/or having obesity with a body mass index (BMI) greater than 30 * Patient having given free, informed and written consent * Patient affiliated to a health insurance system Inclusion Criteria: * Glasgow score = 15 * Need during use of non-invasive ventilation Exclusion Criteria: * Procedure to be carried out in extreme urgency (PaCO2 too high and leading to an immediate vital risk, and / or PaO2 too low) on medical decision * Confusional state making hypnosis impossible * Decompensated psychiatric illness * Patient entering with an NIV in place already installed in another department. The subject becomes included again at the end of the treatment with NIV if however he needs it again. * Patient already included in the study during previous non-invasive ventilation * Patient participating in research involving an interventional human person (category 1) on an analgesic / sedative medication * A person of full age subject to legal protection (safeguard of justice, curators, guardianship) or deprived of liberty
Where this trial is running
Rennes, Brittany Region
- Rennes University Hospital — Rennes, Brittany Region, France (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.